Online citations, reference lists, and bibliographies.
← Back to Search

Combination Low Dose Cyclosporin A And Steroid Therapy In Chronic Intraocular Inflammation

H. Towler, P. H. Whiting, J. Forrester
Published 1990 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Thirteen patients with chronic intraocular inflammation which had not been adequately controlled with oral prednisolone entered into an open study of low-dose Cyclosporin A (mean 4.1 mg/kg/day) combined when required with oral prednisolone (15 mg prednisolone per day or less). The mean duration of treatment was 26 months (range 8-44) over a mean follow-up period of 29 months (range 8-49). Visual acuity improved overall in ten patients, and remained stable in three. Six patients have completed a course of Cyclosporin A therapy, and four of these patients have retained their visual improvement. Two have returned to the pretreatment level of vision. Only one patient has required conversion to alternative immunosuppressive therapy. The mean serum creatinine concentration had increased significantly by 26% after six months (p<0.05) and 32% after one year (p<0.01) but remained stable during the subsequent 18 months. Four patients developed hypertension requiring hypotensive therapy. On cessation of CsA treatment, the mean serum creatinine concentration fell to the upper reference limit. The elevation of serum creatinine concentration was significantly higher in patients who either developed hypertension during Cyclosporin A therapy or who were previously known to be hypertensive. Patients with nephrotoxicity were significantly older than those in whom serum creatinine concentration remained within the reference range. Lithium clearance studies showed evidence of proximal renal tubular dysfunction which was partially reversible on dose reduction or withdrawal.
This paper references
10.1136/bjo.71.5.387
Short term cyclosporin A treatment of Behçet's disease.
A. Müftüoğlu (1987)
10.1016/S0140-6736(84)91166-8
INTERSTITIAL FIBROSIS IN RENAL ALLOGRAFTS AFTER 12 TO 46 MONTHS OF CYCLOSPORIN TREATMENT: BENEFICIAL EFFECT OF LOW DOSES IN EARLY POST-TRANSPLANTATION PERIOD
G. Klintmalm (1984)
10.1172/JCI110138
Cyclosporin a. Inhibition of experimental autoimmune uveitis in Lewis rats.
R. Nussenblatt (1981)
10.1016/0002-9343(84)90356-5
Side effects of systemic cyclosporine in patients not undergoing transplantation.
A. Palestine (1984)
10.1016/S0140-6736(83)90230-1
TREATMENT OF INTRAOCULAR INFLAMMATORY DISEASE WITH CYCLOSPORIN A
RobertB. Nussenblatt (1983)
10.1016/S0140-6736(84)90994-2
REVERSIBILITY OF LYMPHOMAS AND LYMPHOPROLIFERATIVE LESIONS DEVELOPING UNDER CYCLOSPORIN-STEROID THERAPY
T. Starzl (1984)
10.1136/bmj.2.6047.1287
Hypertension after renal transplantation.
C. Bachy (1976)
Chronic intraocular inflammation.
J. Forrester (1985)
Cyclos ­ po { in and prednisone v . prednisone in treatment of Graves ' ophthalmopathy : a controlled , ran ­ domised and prospective study
G Kahaly (1988)
Hyper ­ tension after renal
Chapman
10.1056/NEJM198605153142005
Renal histopathologic alterations in patients treated with cyclosporine for uveitis.
A. Palestine (1986)
Inhibition of experimental auto­ immune uveitis in Lewis rats
A. Cyclosporin (1981)
10.1038/eye.1989.39
Low dose cyclosporin a therapy in chronic posterior uveitis
H. M. Towler (1989)
10.1016/0002-9343(86)90292-5
Renal tubular function in cyclosporine-treated patients.
A. Palestine (1986)
10.1016/S0002-9394(14)77814-6
Cyclosporin A therapy in the treatment of intraocular inflammatory disease resistant to systemic corticosteroids and cytotoxic agents.
R. Nussenblatt (1983)
10.1016/S0161-6420(85)34001-0
Standardization of vitreal inflammatory activity in intermediate and posterior uveitis.
R. Nussenblatt (1985)
Hypertension in renal transplant recipients on cyclosporin A and corticosteroids and azathioprine.
D. Hamilton (1982)
10.1159/000183252
Lithium clearance: a new method for determining proximal and distal tubular reabsorption of sodium and water.
K. Thomsen (1984)
10.1097/00007890-198706000-00018
Hypertension after renal transplantation. A comparison of cyclosporine and conventional immunosuppression.
J. Chapman (1987)
Nifedipine increases GFR in chronic Cyclosporin - treated renal transplant recipients
PG Mcnally (1986)
10.1093/RHEUMATOLOGY/26.4.285
Cyclosporin A in the treatment of severe Behçet's uveitis.
A. Binder (1987)
10.1016/S0140-6736(89)92381-7
DOUBLE-MASKED TRIAL OF CYCLOSPORIN VERSUS COLCHICINE AND LONG-TERM OPEN STUDY OF CYCLOSPORIN IN BEHÇET'S DISEASE
K. Masuda (1989)
10.1001/ARCHINTE.1986.00360220169028
Renal interstitial fibrosis and vascular changes. Occurrence in patients with autoimmune diseases treated with cyclosporine.
K. Svenson (1986)
10.1042/CS077034PB
The effect of nifedipine on graft function in renal allograft recipients treated with cyclosporin A.
D. Propper (1989)
Reversi ­ bility of lymphomas and Iymphoproliferative lesions developing under cyclosporine - steroid therapy
TE Starzl (1984)
10.1111/j.1365-2362.1986.tb01016.x
Ciclosporin and prednisone v. prednisone in treatment of Graves' ophthalmopathy: a controlled, randomized and prospective study
G. Kahaly (1986)



This paper is referenced by
10.1016/S0161-6420(97)30144-4
Systemic cyclosporine A in severe atopic keratoconjunctivitis.
T. Hoang-xuan (1997)
10.1089/jop.2016.0155
Cyclosporine: A Historical Perspective on Its Role in the Treatment of Noninfectious Uveitis.
W. M. Smith (2017)
10.1016/0896-8411(92)90040-W
The expanding use of immunosuppression in the treatment of non-infectious ocular disease.
R. Nussenblatt (1992)
Oftalmía simpática: serie de casos en un centro de referencia oftalmológico de la Ciudad de México
Jorge Martín del Campo-Briceño (2009)
10.1007/978-1-4899-1167-4_27
Cyclosporine a in the Treatment of Dermatologic Diseases
M. Fradin (1992)
10.1111/j.1525-1470.2009.00902.x
Trichomegaly in a 3‐Year‐Old Girl with Alopecia Areata
M. Nazareth (2009)
Anterior uveitis in children
Koon-man Lam (2005)
10.1093/NDT/11.6.1159
Cyclosporin-induced trichomegaly of accessory lashes as a cause of ocular irritation.
D. Jayamanne (1996)
10.1136/bjo.81.12.1107
Immunosuppressive therapy for chronic uveitis: optimising therapy with steroids and cyclosporin A
A. Dick (1997)
10.1097/00004397-200004000-00007
Diagnostic and Therapeutic Approach to Patients With Retinal Vasculitis
M. Stanford (2000)
10.1097/00004397-200604620-00013
Immunomodulatory therapy for the treatment of ocular inflammatory disease: evidence-based medicine recommendations for use.
E. Kim (2006)
10.1080/09273940590951034
Immunomodulatory Therapy for Ocular Inflammatory Disease: A Basic Manual and Review of the Literature
A. Okada (2005)
10.1177/1358863X9500600307
Immune Retinal Vascular Disease
V. Calder (1995)
10.1016/j.ophtha.2009.08.010
Cyclosporine for ocular inflammatory diseases.
R. O. Kacmaz (2010)
10.1007/s10238-004-0045-0
Behcet’s disease
S. Al-Mutawa (2004)
Efficacité et tolérance des immunoglobulines intraveineuses dans le traitement de la rétinochoroïdopathie de type Birdshot
N. Cassoux (2002)
10.1016/j.semarthrit.2010.05.008
Systematic review on the effectiveness of immunosuppressants and biological therapies in the treatment of autoimmune posterior uveitis.
E. Pato (2011)
10.1038/eye.1994.10
Immunomodulation of experimental autoimmune uveoretinitis: A model of tolerance induction with retinal antigens
A. Dick (1994)
10.1016/B978-1-4377-0667-3.00012-6
7 – Philosophy, Goals, and Approaches to Medical Therapy
R. Nussenblatt (2010)
10.1016/S0161-6420(96)30683-0
Low-dose cyclosporin A therapy in treating chronic, noninfectious uveitis.
A. Vitale (1996)
10.1007/978-1-4899-1167-4_26
Immune Therapy for Autoimmune Uveitis
R. Nussenblatt (1992)
Chapter 26 IMMUNE THERAPY FOR AUTOIMMUNE UVEITIS
R. Nussenblatt (1992)
10.3109/09273949609079637
Antineutrophil cytoplasmic antibodies in chronic idiopathic intraocular inflammatory disease.
T. K. Chan (1996)
10.1136/bjo.78.1.1
The treatment of chronic uveitic macular oedema.
A. Dick (1994)
10.1016/S0161-6420(98)91120-4
Cyclosporine therapy for severe sight-threatening uveitis in children and adolescents.
R. C. Walton (1998)
10.1016/0896-8411(92)90041-N
Low-dose cyclosporin therapy of ocular inflammation: preliminary report of a long-term follow-up study.
H. Towler (1992)
10.1111/j.1442-9071.2005.00904.x
Clinical outcome of chronic immunosuppression in patients with non‐infectious uveitis
V. Menezo (2005)
10.3109/02713689208999536
The use of lithium clearance studies in the early detection of cyclosporin A (CsA) nephrotoxicity: a protocol of renal function assessment with CsA therapy.
A. Dick (1992)
10.2165/00003495-199549020-00006
The Diagnosis and Management of Uveitis
E. Anglade (2012)
10.1016/j.ijpharm.2012.12.033
A new drug delivery system inhibits uveitis in an animal model after cataract surgery.
S. Eperon (2013)
10.1111/j.1749-6632.1993.tb17166.x
Treatment of Autoimmune Uveitis
S. Whitcup (1993)
10.1038/EYE.1992.95
Sympathetic ophthalmia: Visual results with modern immunosuppressive therapy
K. Hakin (1992)
See more
Semantic Scholar Logo Some data provided by SemanticScholar